Telomir Pharmaceuticals reports new in vitro data on Telomir-1 epigenetic activity
PositiveFinancial Markets

Telomir Pharmaceuticals has announced promising new in vitro data regarding the epigenetic activity of its drug candidate, Telomir-1. This development is significant as it could lead to advancements in treatments for various diseases, showcasing the company's commitment to innovative research in the pharmaceutical field.
— Curated by the World Pulse Now AI Editorial System